Gold nanoparticle biosensor detects early liver fibrosis from tiny blood sample

A research team led by Professor Jinsung Park of Sungkyunkwan University’s Department of Biomechatronic Engineering has announced the development of an ultrasensitive electrochemical biosensor that can detect early‑stage liver fibrosis from a minimal blood sample. The device, which was created in collaboration with Professor Pil‑Soo Sung of the Catholic University of Korea’s College of Medicine and Professor Si‑Hyun Bae, president of Eunpyeong St. Mary’s Hospital, offers a non‑invasive alternative to the traditional liver biopsy. The study’s results were published in the *Chemical Engineering Journal*.

The biosensor employs advanced electrochemical techniques to identify biomarkers associated with liver scarring, achieving high sensitivity and specificity even with limited sample volumes. By integrating engineering principles with clinical expertise, the team has created a tool that could enable earlier diagnosis and monitoring of liver disease, potentially improving patient outcomes and reducing the need for painful tissue sampling. The interdisciplinary approach underscores the growing synergy between biomedical engineering and medical diagnostics.

If validated in larger clinical trials, the sensor could become a routine screening method for liver fibrosis, allowing clinicians to intervene sooner and tailor treatment plans more effectively. The publication of these findings marks a significant step toward more accessible, patient‑friendly liver disease diagnostics.